USDA hemp licences revoked for marijuana growers in Germany; German legalization changed; Feds pushed to saliva test for cannabis; AZ & Indiana psilocybin
Subscribe and receive Marijuana Moment’s weekly newsletter delivered to your inbox each weekday morning. You’ll always be up-to-date on the latest cannabis news.
Your support makes Marijuana Moment possible…
What do you think a journalist does? You, the reader!
Subscribe for $25/month to help us continue our research, interviews and reporting of all cannabis news. You’ll also get access to the Bill Tracker, which will give you the latest information about drug policy reforms in the U.S.
Join Marijuana Moment for $25/month to support our work: https://www.patreon.com/marijuanamoment
Top Things to Know
The New York Cannabis Control Board has approved settlement agreements that will end the litigation that prevented hundreds of marijuana dispensaries for social equity from opening in New York.
German negotiators agreed to make changes to the draft bill on marijuana legalization. The final vote is expected to be held in the Bundestag this week.
According to reports, the U.S. Department of Agriculture has revoked hemp licenses from farmers who grow marijuana simultaneously under state-approved programmes.
Public transit groups are urging the U.S. Department of Health and Human Services to quickly certify laboratories to test for drugs like marijuana and other drugs by using saliva rather than urine. This will mean that bus drivers and train operators won’t be punished for drug use weeks old when they weren’t intoxicated at work.
Indiana’s Interim Study Committee on Public Health, Behavioral Health and Human Services recommends that lawmakers approve a psilocybin-therapy pilot program during the 2024 session.
Arizona’s Psilocybin Research Advisory Council is holding its first meeting Tuesday, to start the process of awarding grant funding of $5 million to support research into psychedelic mushroom therapeutic potential.
Federal
The Congressional Research Service has published a study on the impact of drug crimes for the Armed Career Criminal Act. This act makes it a criminal offense for felons to possess firearms.
On December 5, the Substance Abuse and Mental Health Services Administration Drug Testing Advisory Board is scheduled to discuss “laboratory created cannabinoids and contaminants in commercially-available products”.
/ STATES
Indiana’s House Speaker said, “No one has yet made a convincing case to me on why legalizing cannabis or having more people in Indiana use cannabis is a good thing.”
The South Dakota Medical Marijuana Oversight Committee of the legislature heard testimony on a proposal that would require employees at medical cannabis dispensaries to receive formal training.
Illinois lawmakers have a spat with McHenry County state’s Attorney over his attempt to force marijuana shops to display warnings regarding alleged risks of cannabis use.
California activists who were behind the recently rescinded ballot measure to create a psychedelics-funded research agency have discussed the reasons why the measure was withdrawn.
The Maryland Supreme Court refused to review an injunction issued by a lower court that prohibited the sale of certain hemp products without a license.
Arizona regulators have sent out a notice regarding a voluntary recall for cannabis products because of possible contamination by aspergillus.
Alabama regulators voted to discard our third-party score on medical cannabis license applications.
Minnesota’s interim top cannabis regulator spoke of efforts to staff the Office of Cannabis Management and oversee legalization implementation.
Maine’s top cannabis regulator has said that he will press lawmakers to pass medical cannabis testing in the 2024 legislative session.
On Wednesday, Vermont regulators are expected to consider recommendations for marijuana business licensing and the upcoming prequalification period.
—
Marijuana Moment tracks more than 1,000 cannabis and drug policy bills that have been introduced in state legislatures, and Congress. Patreon supporters who pledge at least $25/month gain access to our interactive charts, maps and hearing calendar.
Discover more about our marijuana bills tracker. Become a Patreon supporter to gain access.
—
/ LOCAL
A marijuana business in Jersey City, New Jersey is suing officials. The business claims that another business which has ties to an ex-governor who is running for the mayorship was not properly approved to operate near its location.
Lewes and Seaford officials in Delaware are examining proposals to limit where marijuana businesses may operate.
INTERNATIONAL
Daniel Noboa, the president of Ecuador, has repealed an old policy which allowed those caught with small amounts to drugs to be released from prison.
The Philippine House Committee on Dangerous Drugs will vote on a bill to legalize medical cannabis.
Zimbabwe’s Constitutional Court has been asked to review an appeal from the High Court, which dismissed a lawsuit that sought to reverse marijuana criminalization.
Canadian regulators have approved Epidiolex for use as an adjunctive therapy to treat seizures caused by Lennox Gastaut syndrome, Dravet Syndrome, or Tuberous Sclerosis Complex.
SCIENCE AND HEALTH
According to a review, “a large amount of research suggests that cannabinoids may hold promise in the treatment of skin cancer, eczema and psoriasis.” However, “most available data is at the preclinical phase.”
/ ADVOCACY / OPINION AND ANALYSIS
The Lancet editorial council endorsed drug decriminalization.
/ BUSINESS
Treez and Metrc have partnered to create “the cannabis industries first Global Product Catalog.”
Rhode Island retailers have sold legal marijuana products worth $9.4 Million in October.
Subscribe to Marijuana Moment by for daily updates in your mailbox.
The article New York cannabis lawsuit settlement (Newsletter for November 28, 2023) first appeared on Marijuana Moment.
